To develop and evaluate the use of cognitive monitoring for detecting episo
des of acute, excess cognitive decline in individual Alzheimer's disease (A
D) patients, the authors conducted six repeated cognitive assessments over
II weeks on 41 ootherwise healthy people with mild-to-moderate AD. Patients
demonstrated stable cognitive performance over II weeks on seven standard
neuropsychological tests. Prediction intervals quantitatively defined the e
xpected limits of cognitive decline They indicated with 90% certainty that
over the 11-week period, healthy mild-to-moderate AD patients should not de
cline more than 4 points on the Word List Recall test, 3 points on the Digi
t Span test, or 8 items on the Digit Symbol or Verbal fluency rests. The co
gnitive stability of healthy AD patients indicates that it is possible to m
onitor them for acute, excess cognitive decline.